QLTI – QLT Inc, is a Biotechnology company, engaged in development and commercialization of ocular products.


Fundamentals Previously closed at 1.43
Day’s high 1.47
Day’s low 1.41
P/E ratio NA
EPS -0.74


Analysts opinion After a restructuring bout of several years, and cancelled merger attempts with Auxiliam Pharma and InSite Vision, QLT’s price had dropped 64%. Now, QLT and Aegerion have announced a strategic merger, resulting in a combined company named “Novelion Therepeutics”. Under the merger terms, 1 share of Aegerion will be given in return for 1.0256 shares of QLT. An investor syndicate will be purchasing $22 Million worth QLT stocks at $1.76 per stock. Analyst confidence meter, a proprietary algorithm of Stockal gives75% buy based on analyst ratings.
Sentiments The sentiment index is 200% positive according to Stockal proprietary algorithm.
Social Media Pulse The stock has 50% lower social media chatter than usual.


Leave a Reply

Your email address will not be published. Required fields are marked *